O

    Omada Health, Inc. Common Stock (OMDA)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $24.55
    +0.86 (+3.63%)

    Market Cap: $1.50B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    80%(4/5)
    Avg Surprise
    +252.24%
    Streak
    4 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.10
    Range$0.09 - $0.12
    4 analysts
    EPS Revisions
    2
    0
    7d
    2
    0
    30d
    EPS Estimate Drift
    90d ago$0.09-13.0%
    60d ago$0.09-13.0%
    30d ago$0.09-12.9%
    7d ago$0.08-20.5%
    Current$0.10
    Revenue Consensus
    $86M
    Range$85M - $86M
    9 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.31
    Range$0.26 - $0.36
    5 analysts
    Revenue Consensus
    $99M
    Range$97M - $105M
    11 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.31---
    Sep 26EST
    		-$0.10---
    Jun 26
    Reported Aug 6
    		$0.08$-0.02+500.00%Beat+136.4%
    Mar 26
    Reported May 7
    		$0.05$-0.04+225.00%Beat+138.5%
    Dec 25
    Reported Mar 5
    		$0.16$0.03+440.00%Beat-
    Sep 25
    Reported Nov 6
    		$0.03N/A+142.86%Beat-
    Jun 25
    Reported Aug 7
    		$-0.22$-0.15-46.67%Miss-
    Mar 25
    Reported May 9
    		$-0.13$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio76.24EV/EBITDA121.96x
    Price/FCF85.53xFCF Yield1.17%
    Profitability
    Profit Margin1.39%Operating Margin4.04%
    ROE1.84%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage0.48x
    Current Ratio3.91xQuick Ratio3.85x
    Trading Statistics
    BetaN/AAvg Volume1.41M
    52-Week High$26.9152-Week Low$10.28

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$24.03
    SMA 20$23.39
    SMA 50$22.32
    SMA 200$16.94
    EMA 10$23.95
    EMA 20$23.45
    EMA 50$21.96
    EMA 200$18.99

    MACD

    Line: 0.71Signal: 0.73Hist: -0.02

    ADX

    ADX: 32.8+DI: 31.0-DI: 14.9

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down12.0
    PSAR$22.73

    Bollinger Bands

    Upper Band$26.74
    Lower Band$20.05
    %B Position2860%(Upper)
    Band Width0.67

    RSI (14-Day)

    Neutral
    60.7

    Momentum Oscillators

    Stoch %K37.1
    Stoch %D48.7
    Williams %R-44.2
    ROC (10d)3.4%
    Momentum0.80
    CCI (20d)48.2
    MFI (14d)47.8

    Volatility Measures

    ATR (14d)$1.08(4.4%)
    StdDev (20d)1.67
    Hist Vol86.0%(High)

    Volume Flow

    VWAP$24.26
    OBV18.4M
    AD Line-7.2M
    CMF (20d)0.072

    Volume Metrics

    Avg Vol (20d)1.4M
    Vol Ratio1.0x
    VWMA (20d)$23.26

    Pivot Points

    R3$25.29
    R2$24.94
    R1$24.32
    Pivot Point$23.97
    S1$23.35
    S2$23.00
    S3$22.38

    Advanced Oscillators

    TSI18.16
    Ultimate Osc40.2
    KST105.08

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$87.83M$78.05M$75.85M$68.03M$61.37M$54.96M$47.98M$45.52M$41.21M$35.09M$32.55M$32.93M
    Cost of Revenue$24.05M$29.36M$22.18M$22.96M$21.07M$23.06M$16.00M$16.95M$16.38M$17.75M$12.45M$12.86M
    Gross Profit$63.79M$48.69M$53.66M$45.07M$40.31M$31.90M$31.98M$28.56M$24.83M$17.35M$20.10M$20.07M
    Operating Expenses$60.24M$53.47M$50.38M$47.58M$44.65M$40.30M$39.08M$37.09M$34.87M$35.34M$33.49M$34.05M
    R&D$14.63M$12.70M$11.55M$10.30M$10.02M$8.81M$9.17M$8.85M$8.99M$8.90M$8.47M$8.35M
    SG&A$15.72M$13.99M$14.22M$14.34M$12.31M$11.32M$0$10.66M$10.69M$9.25M$0$0
    Operating Income$3.55M$-4,781,000$3.28M$-2,513,000$-4,344,000$-8,396,000$-7,099,000$-8,524,000$-10,037,000$-17,993,000$-13,397,000$-13,977,000
    Interest Income$1.76M$1.83M$1.89M$2.01M$863,000$542,000$0$17,000$85,000$529,000$0$0
    Interest Expense$14,000$18,000$13,000$2.46M$1.09M$1.07M$1.10M$1.15M$1.13M$1.13M$1.13M$1.17M
    Income Before Tax$5.29M$-2,970,000$5.16M$-3,178,000$-5,311,000$-9,448,000$-8,249,000$-9,226,000$-10,692,000$-18,969,000$-13,925,000$-13,965,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$5.29M$-2,970,000$5.16M$-3,178,000$-5,311,000$-9,448,000$-8,249,000$-9,226,000$-10,692,000$-18,969,000$-13,925,000$-13,965,000
    EBITDA$6.10M$-2,315,000$6.62M$-427,000$-2,758,000$-6,740,000$-5,874,000$-6,076,000$-9,645,000$-16,714,000$-11,674,000$-11,690,000
    EBIT$3.55M$-4,781,000$5.17M$-2,725,000$-5,080,000$-8,916,000$-7,152,000$-8,096,000$-9,645,000$-17,839,000$-12,797,000$-12,797,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OMDA

    News

    Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates

    Omada Health, Inc. (OMDA) reported strong Q2 earnings, with $0.15 per share significantly surpassing the Zacks Consensus Estimate of $0.05. The company also exceeded revenue expectations, bringing in $87.84 million against a $61.37 million forecast. This marks the fourth consecutive quarter Omada Health has beaten both EPS and revenue estimates, leading to a year-to-date stock increase of 21.1%.

    Eastern Progress•8/23/26•
    Bullish

    Quantinno Capital Management LP Grows Stock Position in Omada Health, Inc. $OMDA

    Quantinno Capital Management LP significantly increased its stake in Omada Health, Inc. by 464.1% in the first quarter, now owning 58,723 shares valued at $738,000. This comes as Omada Health exceeded quarterly earnings expectations, reporting $0.08 EPS against a $0.02 loss estimate and revenue of $87.83 million, surpassing the $80.93 million forecast. Despite positive analyst sentiment with a "Moderate Buy" consensus and a $26.50 price target, company insiders have sold approximately $5.37 million worth of stock in the last 90 days.

    MarketBeat•8/19/26•
    Bullish

    AlpInvest Partners B.V. Makes New $1.18 Million Investment in Omada Health, Inc. $OMDA

    AlpInvest Partners B.V. has invested $1.18 million in Omada Health, Inc. ($OMDA) by purchasing 53,867 shares, making it their 12th largest position. Other institutional investors have also adjusted their holdings, while company insiders, including the CFO and CEO, have sold significant shares. Analyst ratings for Omada Health are generally positive, with a "Moderate Buy" consensus and an average price target of $26.50.

    MarketBeat•8/19/26•
    Neutral

    GSA Capital Partners LLP Invests $1.29 Million in Omada Health, Inc. $OMDA

    GSA Capital Partners LLP has invested $1.29 million in Omada Health, Inc. by purchasing 58,714 shares. This investment comes as Omada Health exceeded quarterly expectations with $0.08 EPS and $87.83 million in revenue, leading to analysts maintaining a "Moderate Buy" consensus with a $26.50 average price target. Despite insider selling of $5.37 million worth of shares, the stock is trading above its 50-day and 200-day moving averages.

    MarketBeat•8/18/26•
    Bullish

    Walleye Capital LLC Invests $11.65 Million in Omada Health, Inc. $OMDA

    Walleye Capital LLC has invested $11.65 million in Omada Health, Inc. by acquiring 530,670 shares, representing approximately a 0.89% stake. This investment follows strong quarterly earnings from Omada Health, which surpassed revenue and EPS expectations. Despite positive analyst sentiment and a "Moderate Buy" consensus, company insiders sold a significant amount of shares totaling $5.37 million in the last quarter.

    MarketBeat•8/15/26•
    Somewhat-Bullish

    Frequently Asked Questions About OMDA

    Does OMDA pay dividends?
    Omada Health, Inc. Common Stock (OMDA) does not currently pay a regular dividend.
    What is OMDA's P/E ratio?
    Omada Health, Inc. Common Stock has a price-to-earnings (P/E) ratio of 76.24.
    What is OMDA's market cap?
    Omada Health, Inc. Common Stock (OMDA) has a market capitalization of $1.50B with a current stock price of $24.55.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In